You J - Search Results

1

Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. Among authors: you j. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.

2

Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer.

Chen Y, Zhang L, Yan B, Zeng Z, Hui Z, Zhang R, Ren X, You J. Chen Y, et al. Among authors: you j. Transl Lung Cancer Res. 2020 Jun;9(3):761-767. doi: 10.21037/tlcr-20-539. Transl Lung Cancer Res. 2020. PMID: 32676337 Free PMC article.

3

Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited-stage small-cell lung cancer.

Lu M, Zhang R, Qi LS, Wang YL, Sun XX, You J. Lu M, et al. Among authors: you j. Thorac Cancer. 2022 Nov;13(22):3208-3216. doi: 10.1111/1759-7714.14679. Epub 2022 Oct 8. Thorac Cancer. 2022. PMID: 36208136 Free PMC article.

4

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer.

Chen Y, Yan B, Zhang R, Zhao G, You J. Chen Y, et al. Among authors: you j. Heliyon. 2023 Sep 16;9(9):e19818. doi: 10.1016/j.heliyon.2023.e19818. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809935 Free PMC article.

5

[Efficacy of adjuvant chemotherapy after left pneumonectomy on non-small cell lung cancer].

Wang M, Wang CL, Gong LQ, Gu F, Su YJ, You J. Wang M, et al. Among authors: you j. Ai Zheng. 2007 Dec;26(12):1365-8. Ai Zheng. 2007. PMID: 18076803 Free article. Chinese.

6

Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.

Sun BS, You J, Li Y, Zhang ZF, Wang CL. Sun BS, et al. Among authors: you j. Chin Med J (Engl). 2013;126(9):1683-8. Chin Med J (Engl). 2013. PMID: 23652051

7

Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.

Sun BS, Li Y, Zhang ZF, You J, Wang CL. Sun BS, et al. Among authors: you j. Ann Thorac Surg. 2013 Dec;96(6):1943-51. doi: 10.1016/j.athoracsur.2013.07.089. Epub 2013 Oct 3. Ann Thorac Surg. 2013. PMID: 24094519

8

[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with  Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].

Ren H, Xu W, You J, Song X, Huang H, Zhao N, Ren X, Zhang X. Ren H, et al. Among authors: you j. Zhongguo Fei Ai Za Zhi. 2016 Apr 20;19(4):192-9. doi: 10.3779/j.issn.1009-3419.2016.04.03. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27118646 Free PMC article. Chinese.

9

Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects.

Zhao X, Su Y, You J, Gong L, Zhang Z, Wang M, Zhao Z, Zhang Z, Li X, Wang C. Zhao X, et al. Among authors: you j. Oncotarget. 2016 Sep 20;7(38):62619-62626. doi: 10.18632/oncotarget.11547. Oncotarget. 2016. PMID: 27566586 Free PMC article. Clinical Trial.

10

New insight on the correlation of metabolic status on ¹⁸F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer.

Wang Y, Zhao N, Wu Z, Pan N, Shen X, Liu T, Wei F, You J, Xu W, Ren X. Wang Y, et al. Among authors: you j. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1127-1136. doi: 10.1007/s00259-019-04500-7. Epub 2019 Sep 9. Eur J Nucl Med Mol Imaging. 2020. PMID: 31502013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,661 results

Search Page

Filters